Literature DB >> 17941061

Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation.

Suhag H Parikh1, Paul Szabolcs, Vinod K Prasad, Sonali Lakshminarayanan, Paul L Martin, Timothy A Driscoll, Joanne Kurtzberg.   

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is curative for chronic granulomatous disease (CGD), but many patients lack a suitably matched related donor. We report successful outcomes after mismatched, unrelated-donor umbilical cord blood transplantation (uUCBT) in two boys with X-linked CGD. Both patients experienced autologous recovery after first transplants, required second transplants to achieve durable donor engraftment, and are alive 27 and 15 months post-transplant. Both had invasive fungal disease and received granulocyte transfusions. In conclusion, uUCBT is effective in children with CGD, but immunosuppression in the conditioning regimen may need to be increased to decrease the risk of graft rejection. 2007 Wiley-Liss, Inc

Entities:  

Mesh:

Year:  2007        PMID: 17941061     DOI: 10.1002/pbc.21365

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

Review 1.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.

Authors:  Elizabeth M Kang; Betty E Marciano; SukSee DeRavin; Kol A Zarember; Steven M Holland; Harry L Malech
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

2.  Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection.

Authors:  Keisuke Kato; Yasuko Kojima; Chie Kobayashi; Kazumasa Mitsui; Ryoko Nakajima-Yamaguchi; Kazuko Kudo; Toshihiro Yanai; Ai Yoshimi; Tomohei Nakao; Tomohiro Morio; Mureo Kasahara; Kazutoshi Koike; Masahiro Tsuchida
Journal:  Int J Hematol       Date:  2011-10-21       Impact factor: 2.490

3.  Advances in treatment for chronic granulomatous disease.

Authors:  Elizabeth M Kang; Harry L Malech
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  Implication of cord blood for cell-based therapy in refractory childhood diseases.

Authors:  Young-Ho Lee
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

5.  Successful unrelated donor cord blood transplantation for chronic granulomatous disease.

Authors:  Tang-Her Jaing; Wen I Lee; Po-Jen Cheng; Shih-Hsiang Chen; Jing-Long Huang; Yung-Kuei Soong
Journal:  Int J Hematol       Date:  2010-03-12       Impact factor: 2.490

6.  A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004-2017).

Authors:  Qinhua Zhou; Xiaoying Hui; Wenjing Ying; Jia Hou; Wenjie Wang; Danru Liu; Ying Wang; Yeheng Yu; Jingyi Wang; Jinqiao Sun; Qian Zhang; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2018-03-20       Impact factor: 8.317

7.  Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

Authors:  Priti Tewari; Paul L Martin; Adam Mendizabal; Suhag H Parikh; Kristin M Page; Timothy A Driscoll; Harry L Malech; Joanne Kurtzberg; Vinod K Prasad
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-10       Impact factor: 5.742

Review 8.  Update on umbilical cord blood transplantation.

Authors:  Joanne Kurtzberg
Journal:  Curr Opin Pediatr       Date:  2009-02       Impact factor: 2.856

9.  Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.

Authors:  Peter B Kang; Hart G W Lidov; Alexander J White; Matthew Mitchell; Anuradha Balasubramanian; Elicia Estrella; Richard R Bennett; Basil T Darras; Frederic D Shapiro; Barbara J Bambach; Joanne Kurtzberg; Emanuela Gussoni; Louis M Kunkel
Journal:  Muscle Nerve       Date:  2010-06       Impact factor: 3.217

Review 10.  Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.

Authors:  James A Connelly; Rebecca Marsh; Suhag Parikh; Julie-An Talano
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-09       Impact factor: 3.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.